Publication | Closed Access
Phase I clinical trial of a new antitumor agent, 4'-demethylepipodophyllotoxin 9-(4,6-O-ethylidene- -D-glucopyranoside) (NSC-141540; VP-16-213).
42
Citations
0
References
1972
Year
Medicinal ChemistryOncology4'-Demethylepipodophyllotoxin 9-MedicinePharmacotherapyAnti-cancer AgentNew Antitumor AgentCancer TreatmentPharmacologyRadiation OncologyCancer ResearchDrug Discovery
No additional data available for this publication yet. Check back later!